Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0RPPIJ
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
CD184-tacrolimus antibody drug conjugate
|
|||||
| Synonyms |
CD184-tacrolimus antibody drug conjugate (Ambrx)
Click to Show/Hide
|
|||||
| Organization |
Ambrx, Inc.; Ambrx Biopharma, Inc.
|
|||||
| Drug Status |
Terminated
|
|||||
| Indication |
In total 1 Indication(s)
Inflammation [ICD11:1A00-CA43]
Terminated
|
|||||
| Antibody Name |
Undisclosed
|
|||||
| Antigen Name |
C-X-C chemokine receptor type 4 (CXCR4)
|
Antigen Info | ||||
| Payload Name |
Tacrolimus
|
Payload Info | ||||
| Therapeutic Target |
Peptidyl-prolyl cis-trans isomerase FKBP1A (FKBP1A)
|
Target Info | ||||
| Linker Name |
Undisclosed
|
|||||
If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.